en
Rifampicin

Rifampicin

$RIF

90.93 %(1Y)

$0.00021352

Price chart

Statistics

Price change (24h):

1.26%

High (24h):

$0.00022135

Low (24h):

$0.00021245

Volume (24h):

$797.25

Market Cap:

$213.45K

All Time High:

99.91% $0.25

Nov 18, 2024

All Time Low:

34% $0.00

Jun 6, 2026

About Rifampicin

Rifampicin (RIF) is a cryptocurrency. It sits at the odd intersection of meme coin virality and the meticulous rigors of Decentralized Science (DeSci), catalogued under both the Solana and Pump.fun ecosystems.

The token’s entire utility orbits the Pump Science platform, a gamified longevity research arena where capital meets the petri dish. That specific friction it tears open is the closed, slow-moving gate of traditional biotech funding, replacing it with a live-streamed, tokenized prediction market for anti-aging compounds. Every trade becomes a micro-wager on cellular senescence.

Rifampicin operates on the Solana network. The chain’s sub-second finality and negligible fees absorb the frantic, high-frequency trading patterns typical of meme-adjacent assets without choking on gas costs.

Technically, the asset exists as an SPL token, natively inheriting Solana’s composability with decentralized exchanges and automated market makers. The smart contract, traceable at its mint address GJtJuWD9qYcC…, anchors a supply that requires no bridging or wrapping. No Ethereum Virtual Machine compatibility, no Byzantine Fault Tolerance to configure—just a lightweight SPL ledger entry that draws its security from Solana's proof-of-stake validator set.

The token bubbled up through Pump.fun’s permissionless launchpad. While no single founder’s name tags the token explicitly, its parent architecture—the Pump Science experiment suite—materialized from the Molecule ecosystem, which has spent years building infrastructure to tokenize intellectual property and early-stage pharmaceutical research. The whitepaper’s gitbook documents the mechanics, but the asset’s soul is the continuous, public data stream of Caenorhabditis elegans worms swimming in Rifampicin solutions.

The project’s long-term design is a lateral attack on the scientific funding bottleneck. Instead of relying on grant committees, the token grafts a speculative layer directly onto preclinical longevity trials, making the testing of senolytic compounds a matter of transparent, financially incentivized crowd observation. This is a market-based instrument for hypothesis validation, not a pharmaceutical endorsement.

Mechanically, the token acts as a pure representation of a single longevity experiment. Its price oscillates not on earnings reports but on the visual, real-time data of nematode motility, lifespan extension curves, and oxidative stress resistance. The token is the settlement layer for expectations about whether an old antibiotic can teach cells to withstand time.

Speculators buy the token to anchor a belief in Rifampicin’s pro-longevity effects, their position tracking the compound’s performance in an ongoing worm experiment. The Pump Science interface streams the biological data openly; a spike in median survival among the model organisms creates a reflexive pressure on the token’s order books. No governance votes, no staking yields—just a vertiginous correlation between a pipette and a candlestick chart.

Rifampicin has a maximum supply of 1,000,000,000 tokens. Currently, 999,655,351.80 are in circulation. With a market capitalization of $266,893.00, Rifampicin ranks #4,440 among all cryptocurrencies.

Rifampicin Historical Price Data

Date Open Close High Low
$0.00 $0.00 $0.00 $0.00
$0.00 $0.00 $0.00 $0.00
$0.00 $0.00 $0.00 $0.00
$0.00 $0.00 $0.00 $0.00
$0.00 $0.00 $0.00 $0.00
$0.00 $0.00 $0.00 $0.00
$0.00 $0.00 $0.00 $0.00
$0.00 $0.00 $0.00 $0.00
Why is manual trading Rifampicin a bad idea?
Manual $rif trading
  • Miss perfect entry/exit
  • Emotional decisions
  • Huge time to monitor
Stoic AI
  • AI trades 24/7 automatically Catch every opportunity

  • Zero-emotion algorithm Disciplined strategy

  • Passive income Set & forget automation

20,000+

traders trusted Stoic AI

$200M+

in cumulative assets under management since inception

2015

year of company foundation

Try Automated $RIF Trading

FAQ

  • Rifampicin ($RIF) is a cryptocurrency that can be bought, sold, and traded on major exchanges. Its price changes in real time based on supply, demand, and broader market conditions. You can track the live $RIF price, market cap, and 24-hour trading volume at the top of this page.
  • The current price of Rifampicin ($RIF) is $0.00021352. Over the last 24 hours, it has moved -1.26%. Crypto prices update continuously, so short-term changes can happen quickly.
  • You can buy Rifampicin on major exchanges like Binance, Coinbase, or KuCoin. However, simply buying and holding can be risky due to market volatility.

    The smartest way to manage your $RIF investment is to connect your exchange account to Stoic AI. This allows you to keep funds on your preferred exchange while our institutional-grade algorithm automates the trading strategy for you, aiming to outperform manual trading.
  • Rifampicin's price is influenced by overall crypto market trends, trading volume, investor sentiment, regulatory news, and macroeconomic events. High volatility is common - $RIF can move 5-15% in a single day. This makes timing the market extremely difficult for manual traders but creates opportunities for systematic, data-driven strategies.
  • We can’t provide investment advice. Whether Rifampicin is a good investment depends on your risk tolerance, time horizon, and strategy. Crypto markets are highly volatile and past performance doesn't guarantee future results. Many investors reduce risk by diversifying across multiple assets and using automated strategies that remove emotional decision-making. Always do your own research before investing.
  • Common approaches include buy & hold, discretionary trading based on technical analysis, or automated strategies. Manual trading can be difficult due to fees, timing, and emotional decisions. Stoic AI offers an out-of-the-box automated approach: connect your exchange via trade-only API permissions, choose a strategy, and the system manages portfolio rebalancing 24/7.
  • Stoic AI uses hedge fund-grade quantitative strategies developed by Cindicator, a fintech company with 9+ years of experience and $230M+ in assets under management. The algorithm analyzes price data, volatility, and correlations to build and rebalance a diversified portfolio. $RIF can be included based on real-time market conditions. Over 18,000 customers already use Stoic AI to automate their crypto portfolios.
  • With Stoic AI, your funds stay on your exchange (Binance, Coinbase, KuCoin, etc.) at all times. Stoic connects via read-and-trade-only API keys - it cannot withdraw your funds. The platform uses institutional-grade risk management and has been live-tested through multiple market cycles since 2020, including the 2022 crypto winter. You maintain full control and can disconnect at any time.
  • You can start with as little as $500. There are no lock-ups and no hidden fees. You can try it now and withdraw your funds at any time. Create a Stoic account, connect your exchange using an API key with trading‑only permissions, choose a strategy, and start automated trading. You can stop anytime by revoking the API key on your exchange. Since the funds stay in your exchange wallet, you remain in control of deposits and withdrawals.

Disclaimer:

This website is operated by Cindicator Ltd. (“Cindicator”), a Gibraltar private company. You are solely responsible for compliance with all laws that may apply to you and your use of Cindicator products. Cryptocurrencies and blockchain technologies have been the subject of scrutiny by regulatory bodies worldwide. With respect to your use of Cindicator products, Cindicator makes no representations regarding the applicability or compliance of its products with any laws or regulations, including, without limitation, those related to trading, options, derivatives, or securities. You also assume all legal, economic, and other risks related to your use of Cindicator products, including legal uncertainty, market volatility, and information security risks, among others. Trading in cryptocurrencies and digital assets is highly speculative, and the value of investments can fluctuate dramatically. You may lose a substantial portion or even all of your invested capital, and such trading may not be suitable for everyone. If you are unsure about these risks or your ability to bear potential losses, you should consult with an independent financial advisor before using Cindicator products. Depending on your jurisdiction, access to or use of Cindicator products may be subject to certain legal restrictions or prohibitions. You agree that it is solely your responsibility to determine and comply with any laws and regulations applicable to your use of Cindicator products, and that Cindicator is not responsible for informing you of such requirements.

Cindicator reserves the right to restrict or refuse access to its products for citizens or residents of certain jurisdictions, including those subject to international sanctions or other legal restrictions. All materials provided on this website (including any graphical materials regarding trading strategy performance or P&L) are presented solely for marketing and informational purposes. They do not guarantee any future profits and should not be construed as financial, investment, legal, or other professional advice. Cindicator is not a registered broker-dealer, investment adviser, or regulated financial institution, and the information and services provided do not constitute personal investment advice or a recommendation or offer to buy or sell any securities, cryptocurrencies, or other financial instruments. The information provided herein is summary in nature, does not purport to be complete, and is provided “as is” without any warranty as to its accuracy or completeness. All content may be updated or changed at any time without notice. Past performance is not indicative of future results. To the maximum extent permitted by law, Cindicator (including its directors, officers, and affiliates) shall not be liable for any loss or damage (direct, indirect, special, consequential, or incidental) arising from your use of Cindicator products, this website, or any information contained herein. Please read our Terms of Use for further details. If you do not agree with these terms, please close this site.

Cookie Settings